Brandywine Global Investment Management’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.15M Buy
140,363
+25,600
+22% +$757K 0.03% 401
2025
Q1
$3.43M Buy
114,763
+13,792
+14% +$412K 0.02% 413
2024
Q4
$2.89M Sell
100,971
-149,402
-60% -$4.28M 0.02% 439
2024
Q3
$9.51M Buy
250,373
+85,645
+52% +$3.25M 0.06% 273
2024
Q2
$5.3M Sell
164,728
-41,686
-20% -$1.34M 0.04% 382
2024
Q1
$8.01M Sell
206,414
-167,701
-45% -$6.51M 0.06% 315
2023
Q4
$11.5M Sell
374,115
-9,226
-2% -$284K 0.09% 225
2023
Q3
$8.57M Sell
383,341
-2,405
-0.6% -$53.8K 0.08% 262
2023
Q2
$8.29M Buy
385,746
+11,133
+3% +$239K 0.07% 276
2023
Q1
$8.99M Buy
374,613
+4,935
+1% +$118K 0.07% 262
2022
Q4
$8.58M Buy
369,678
+44,416
+14% +$1.03M 0.07% 261
2022
Q3
$5.21M Buy
325,262
+54,012
+20% +$865K 0.05% 322
2022
Q2
$4.81M Buy
271,250
+28,490
+12% +$505K 0.04% 365
2022
Q1
$4.94M Buy
242,760
+2,538
+1% +$51.7K 0.04% 395
2021
Q4
$4.49M Buy
240,222
+156,849
+188% +$2.93M 0.03% 421
2021
Q3
$1.65M Buy
83,373
+4,636
+6% +$91.5K 0.01% 544
2021
Q2
$1.86M Sell
78,737
-5,205
-6% -$123K 0.01% 542
2021
Q1
$1.99M Sell
83,942
-708
-0.8% -$16.8K 0.02% 524
2020
Q4
$1.7M Sell
84,650
-5,236
-6% -$105K 0.01% 497
2020
Q3
$1.87M Buy
89,886
+14,105
+19% +$294K 0.02% 462
2020
Q2
$1.33M Buy
75,781
+744
+1% +$13K 0.01% 494
2020
Q1
$1.23M Buy
75,037
+489
+0.7% +$7.99K 0.01% 502
2019
Q4
$1.61M Buy
74,548
+11,981
+19% +$259K 0.01% 541
2019
Q3
$719K Buy
+62,567
New +$719K 0.01% 579
2018
Q1
Sell
-105,376
Closed -$1.95M 904
2017
Q4
$1.95M Sell
105,376
-11,623
-10% -$215K 0.01% 553
2017
Q3
$1.23M Buy
+116,999
New +$1.23M 0.01% 578